Costanza ME - Search Results

1

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.

Costanza ME, Weiss RB, Henderson IC, Norton L, Berry DA, Cirrincione C, Winer E, Wood WC, Frei E 3rd, McIntyre OR, Schilsky RL. Costanza ME, et al. J Clin Oncol. 1999 May;17(5):1397-406. doi: 10.1200/JCO.1999.17.5.1397. J Clin Oncol. 1999. PMID: 10334524 Clinical Trial.

2

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.

Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM. Berry DA, et al. J Clin Oncol. 2002 Feb 1;20(3):743-50. doi: 10.1200/JCO.2002.20.3.743. J Clin Oncol. 2002. PMID: 11821456 Clinical Trial.

3

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study.

Ratain MJ, Rosner G, Allen SL, Costanza M, Van Echo DA, Henderson IC, Schilsky RL. Ratain MJ, et al. J Clin Oncol. 1995 Mar;13(3):741-7. doi: 10.1200/JCO.1995.13.3.741. J Clin Oncol. 1995. PMID: 7884434 Clinical Trial.

4

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).

Costanza ME, Berry D, Henderson IC, Ratain MJ, Wu K, Shapiro C, Duggan D, Kalra J, Berkowitz I, Lyss AP. Costanza ME, et al. Clin Cancer Res. 1995 Jul;1(7):699-704. Clin Cancer Res. 1995. PMID: 9816035 Clinical Trial.

5

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study.

Dawson NA, Costanza ME, Korzun AH, Clamon GH, Pollak M, Vogelzang NJ, Carey RW, Norton L. Dawson NA, et al. Among authors: costanza me. Med Pediatr Oncol. 1991;19(4):283-8. doi: 10.1002/mpo.2950190413. Med Pediatr Oncol. 1991. PMID: 1829134 Clinical Trial.

6

A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443.

Budman DR, Korzun AH, Aisner J, Younger J, Silver R, Costanza M, Rice MA, Wood W. Budman DR, et al. Cancer Invest. 1990;8(6):571-5. doi: 10.3109/07357909009018922. Cancer Invest. 1990. PMID: 2292049 Clinical Trial.

7

Impact of a physician intervention program to increase breast cancer screening.

Costanza ME, Zapka JG, Harris DR, Hosmer D, Barth R, Gaw VP, Greene HL, Stoddard AM. Costanza ME, et al. Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec;1(7):581-9. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1302571

8

Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study.

Costanza ME, Greene HL, McManus D, Hoople NE, Barth R. Costanza ME, et al. J Cancer Educ. 1995 Spring;10(1):14-21. doi: 10.1080/08858199509528321. J Cancer Educ. 1995. PMID: 7772460

9

Issues in breast cancer screening in older women.

Costanza ME. Costanza ME. Cancer. 1994 Oct 1;74(7 Suppl):2009-15. doi: 10.1002/1097-0142(19941001)74:7+<2009::aid-cncr2820741704>3.0.co;2-e. Cancer. 1994. PMID: 8087764 Review.

10

Breast cancer screening in older women: overview.

Costanza ME. Costanza ME. J Gerontol. 1992 Nov;47 Spec No:1-3. J Gerontol. 1992. PMID: 1430870 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page